Avitar Current Ratio 1971-1970 | AVTI

Avitar current ratio from 1971 to 1970. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Avitar Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
Avitar, Inc. (Avitar), through its wholly owned subsidiary Avitar Technologies, Inc. (ATI), develops, manufactures, markets and sells diagnostic test products and hydrophilic polyurethane foam disposables fabricated for medical, diagnostics, dental and consumer use. The Company continued the development and marketing of point-of-care oral fluid drugs of abuse tests, which use the Company's foam as the means for collecting the oral fluid sample. Avitar sells its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies and corporations. The Company continues to have applications for its technologies in a variety of other medical/consumer markets. They include a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. Customers for these products include ArthroCare and National Aeronautics and Space Administration (NASA).
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $84.708B 20.34
Becton Dickinson (BDX) United States $54.818B 13.40
Cardinal Health (CAH) United States $35.702B 18.14
Straumann Holding AG (SAUHY) Switzerland $18.832B 0.00
West Pharmaceutical Services (WST) United States $17.650B 35.27
Cooper (COO) United States $12.915B 16.07
Align Technology (ALGN) United States $10.230B 20.16
Henry Schein (HSIC) United States $8.371B 14.81
Merit Medical Systems (MMSI) United States $5.333B 25.73
DENTSPLY SIRONA (XRAY) United States $2.857B 8.37
CONMED (CNMD) United States $1.663B 11.97
STAAR Surgical (STAA) United States $1.358B 0.00
Lifevantage (LFVN) United States $0.165B 17.01
Pro-Dex (PDEX) United States $0.151B 16.59